China SXT Pharmaceuticals, Inc.
SXTC · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $6,082 | $9,917 | $2,359 | $3,393 |
| - Cash | $18,099 | $18,099 | $18,513 | $18,513 |
| + Debt | $984 | $984 | $9,872 | $9,872 |
| Enterprise Value | -$11,033 | -$7,198 | -$6,282 | -$5,248 |
| Revenue | $456 | $456 | $415 | $415 |
| % Growth | 0% | 9.9% | 0% | – |
| Gross Profit | $116 | $116 | $67 | $67 |
| % Margin | 25.5% | 25.5% | 16.2% | 16.2% |
| EBITDA | -$1,014 | -$1,014 | -$285 | -$285 |
| % Margin | -222.6% | -222.6% | -68.7% | -68.7% |
| Net Income | -$1,251 | -$1,251 | -$401 | -$401 |
| % Margin | -274.4% | -274.4% | -96.8% | -96.8% |
| EPS Diluted | -0.51 | -0.51 | -0.99 | -0.99 |
| % Growth | 0% | 48.5% | 0% | – |
| Operating Cash Flow | -$494 | -$494 | -$679 | -$679 |
| Capital Expenditures | -$1 | -$1 | $0 | $0 |
| Free Cash Flow | -$495 | -$495 | -$679 | -$679 |